Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [1] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ben Adeyi
    Beatriz Caballero
    Paul Hodgkins
    Richard Civil
    David R. Coghill
    CNS Drugs, 2014, 28 : 1059 - 1069
  • [2] A head-to-head, double-blind, randomized, phase 3b trial comparing the efficacy of lisdexamfetamine dimesylate with atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Dittmann, Ralf
    Cardo, Esther
    Coghill, David
    Nagy, Peter
    Adeyi, Ben
    Anderson, Colleen
    Caballero, Beatriz
    Higgins, Nicholas
    Hodgkins, Paul
    Civil, Richard
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S222 - S223
  • [3] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Nagy, Peter
    Haege, Alexander
    Coghill, David R.
    Caballero, Beatriz
    Adeyi, Ben
    Anderson, Colleen S.
    Sikirica, Vanja
    Cardo, Esther
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2016, 25 (02) : 141 - 149
  • [4] Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
    Peter Nagy
    Alexander Häge
    David R. Coghill
    Beatriz Caballero
    Ben Adeyi
    Colleen S. Anderson
    Vanja Sikirica
    Esther Cardo
    European Child & Adolescent Psychiatry, 2016, 25 : 141 - 149
  • [5] A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder
    Ni, Hsing-Chang
    Shang, Chi-Yung
    Gau, Susan Shur-Fen
    Lin, Yu-Ju
    Huang, Hui-Chun
    Yang, Li-Kuang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (09) : 1959 - 1973
  • [6] Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials
    Liu, Qiang
    Zhang, Hong
    Fang, Qingqing
    Qin, Lili
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2017, 39 (09) : 854 - 865
  • [7] Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
    Joseph, Alain
    Cloutier, Martin
    Guerin, Annie
    Nitulescu, Roy
    Sikirica, Vanja
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 391 - 405
  • [8] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design
    Brams, Matthew
    Weisler, Richard
    Findling, Robert L.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (07) : 977 - 983
  • [9] Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
    Timothy Wigal
    Matthew Brams
    Maria Gasior
    Joseph Gao
    Liza Squires
    John Giblin
    Behavioral and Brain Functions, 6
  • [10] A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder
    Harfterkamp, Myriam
    van de Loo-Neus, Gigi
    Minderaa, Ruud B.
    van der Gaag, Rutger-Jan
    Escobar, Rodrigo
    Schacht, Alexander
    Pamulapati, Sireesha
    Buitelaar, Jan K.
    Hoekstra, Pieter J.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2012, 51 (07) : 733 - 741
12345